Unclaimed brand
Discover Nona Biosciences' pioneering fully human heavy chain only antibodies (HCAb/VHH) Harbour Mice® platform, driving innovation in next-gen therapeutic modalities. Explore how our advanced single-domain antibody technology accelerates the development of bispecifics, ADCs, CAR-T therapies, and more.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#F15A29
Flamingo
241, 90, 41
15, 88, 55
0, 63, 83, 5
#CCCCCC
Silver
204, 204, 204
0, 0, 80
0, 0, 0, 20
#0A408D
Torea Bay
10, 64, 141
215, 87, 30
93, 55, 0, 45
Nona Biosciences is a leading global biotechnology company specializing in cutting-edge technology innovations. Our mission is to provide a comprehensive solution for partners worldwide, ranging from academic institutions and biotech startups to major biopharmaceutical companies. Through our advanced antibody discovery services, we offer a wide range of integrated solutions, including antigen preparation, animal immunization, single B cell screening, antibody lead generation and engineering, developability assessment, and pharmacological evaluation.
At Nona Biosciences, we leverage our proprietary Harbour Mice® platforms and highly experienced therapeutic antibody discovery team to deliver clinically validated fully human antibody platforms. Our Harbour Mice® platform generates fully human monoclonal antibodies in both H2L2 and heavy-chain-only (HCAb) formats. By integrating this platform with our Beacon® single B cell screening platform, we drive global inventions of transformative next-generation drugs through diversified partnership strategies.
We are committed to empowering global biotherapeutic innovation and offering flexible business models to maximize the value of our customers. Contact Nona Biosciences to explore our comprehensive antibody discovery solutions and technology licensing opportunities
Company type
Public Company
Year founded
2022
Company size
51-200 employees
